AVENUE THERAPEUTICS, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
AVENUE THERAPEUTICS, INC. (ATXI) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $569.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-07
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $569.00K.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $1.20M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $1.83M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2.30M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2026-06-30 | $569.00K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $1.20M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $1.83M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $2.30M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $2.83M 10-Q · filed 2026-08-07 |
| 2025-03-31 | $2.33M 10-Q · filed 2026-08-07 |
| 2024-12-31 | $1.86M 10-Q · filed 2026-08-07 |
| 2024-09-30 | $1.65M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $3.83M 10-Q · filed 2025-11-13 |
| 2024-03-31 | $1.90M 10-Q · filed 2025-08-14 |
| 2023-12-31 | $654.00K 10-K · filed 2026-03-30 |
| 2023-09-30 | -$4.52M 10-Q · filed 2024-11-14 |
| 2023-06-30 | -$6.15M 10-Q · filed 2024-11-14 |
| 2023-03-31 | -$2.16M 10-Q · filed 2024-08-09 |
| 2022-12-31 | $3.27M 10-K · filed 2025-03-31 |
| 2022-09-30 | -$39.00K 10-Q · filed 2023-11-13 |
| 2022-06-30 | $598.00K 10-Q · filed 2023-11-13 |
| 2022-03-31 | $1.16M 10-Q · filed 2023-08-11 |
| 2021-12-31 | $3.45M 10-K · filed 2024-03-18 |
| 2020-12-31 | $2.36M 10-K · filed 2023-03-31 |